The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica A Note on Peptides by Shantanu Out of Singapore